Item 7.01 Regulation FD Disclosure.
On December 13, 2019, Alector, Inc. (the "Company") issued a press release
regarding updates in the Company's clinical and research programs to be shared
at its R&D Day on December 13, 2019 and a separate press release announcing the
appointment of Dr. Richard Scheller and Dr. Thomas Südhof as co-chairs of the
Company's Strategic Portfolio Advice and Review Committee (SPARC). A copy of the
press releases are furnished as Exhibit 99.1 and Exhibit 99.2, respectively, to
this Current Report on Form 8-K and are hereby incorporated by reference into
this Item 7.01 and shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise
subject to liabilities of that section, nor shall such information and exhibit
be incorporated by reference into any filing under the Securities Act of 1933,
as amended, or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
Item 8.01 Other Events.
In connection with Dr. Scheller's service and engagement as a co-chair of SPARC,
the Board determined that Dr. Scheller is no longer considered "independent"
under the rules of NASDAQ and the Securities and Exchange Commission. On
December 6, 2019, the Board re-established the Compensation Committee and
Nominating and Corporate Governance Committee as follows:
Compensation Committee
Mr. David Wehner (Chairperson)
Mr. Louis J. Lavigne, Jr.
Nominating and Corporate Governance Committee
Mr. Terry McGuire (Chairperson)
Dr. Kristine Yaffe
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release dated December 13, 2019.
99.2 Press Release dated December 13, 2019.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses